Soleno Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 8.08 M | $374.07 M | 1.00% | 15.15% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 7.18 M | $332.30 M | 18.53% | 13.46% |
| BLACKROCK, INC. | 02/12/2026 | 3.87 M | $179.26 M | 10.86% | 7.26% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 3.32 M | $153.85 M | 43.71% | 6.23% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.32 M | $153.66 M | -14.97% | 6.22% |
| VANGUARD GROUP INC | 01/29/2026 | 3.06 M | $141.69 M | 9.02% | 5.74% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 2.90 M | $134.27 M | 12.50% | 5.44% |
| STATE STREET CORP | 02/13/2026 | 2.65 M | $122.68 M | 21.93% | 4.97% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.31 M | $60.84 M | 52.13% | 2.46% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.24 M | $57.24 M | 26.18% | 2.32% |
| COMMODORE CAPITAL LP | 02/17/2026 | 1.20 M | $55.56 M | -11.11% | 2.25% |
| BRAIDWELL LP | 02/17/2026 | 1.19 M | $55.00 M | -7.34% | 2.23% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.16 M | $53.87 M | 7.22% | 2.18% |
| POLAR CAPITAL HOLDINGS PLC | 02/17/2026 | 1.14 M | $52.64 M | -4.55% | 2.13% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.11 M | $51.48 M | 310.50% | 2.08% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 1.00 M | $46.30 M | 100.00% | 1.88% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 913.05 K | $42.27 M | 64.38% | 1.71% |
| VIVO CAPITAL, LLC | 02/13/2026 | 894.91 K | $41.43 M | -60.72% | 1.68% |
| INVESCO LTD. | 02/19/2026 | 875.02 K | $40.51 M | -41.69% | 1.64% |
| READYSTATE ASSET MANAGEMENT LP | 02/17/2026 | 874.45 K | $40.49 M | 324.89% | 1.64% |
| FRANKLIN RESOURCES INC | 02/11/2026 | 823.96 K | $38.15 M | -1.41% | 1.55% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 624.13 K | $28.90 M | 13.35% | 1.17% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 621.81 K | $28.79 M | -0.86% | 1.17% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/17/2026 | 618.01 K | $28.61 M | 0.75% | 1.16% |
| ARTIA GLOBAL PARTNERS LP | 02/17/2026 | 533.70 K | $24.71 M | -20.60% | 1.00% |
| IKARIAN CAPITAL, LLC | 02/18/2026 | 528.90 K | $24.49 M | 200.34% | 0.99% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 502.00 K | $23.24 M | 402.00% | 0.94% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 468.65 K | $21.70 M | 579.66% | 0.88% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 449.85 K | $20.82 M | 60.49% | 0.84% |
| EMERALD ADVISERS, LLC | 02/09/2026 | 412.65 K | $19.11 M | -34.27% | 0.77% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 401.19 K | $18.57 M | 3.04% | 0.75% |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 400.00 K | $18.52 M | 77.78% | 0.75% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 02/17/2026 | 399.90 K | $18.52 M | 32.86% | 0.75% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 384.17 K | $17.79 M | 100.00% | 0.72% |
| NORTHERN TRUST CORP | 02/17/2026 | 365.42 K | $16.92 M | 3.16% | 0.69% |
| CATALIO CAPITAL MANAGEMENT, LP | 02/17/2026 | 360.34 K | $16.68 M | -13.84% | 0.68% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 357.30 K | $16.54 M | -15.19% | 0.67% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 342.50 K | $15.86 M | -66.29% | 0.64% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 325.00 K | $15.05 M | 100.00% | 0.61% |
| CITADEL ADVISORS LLC | 02/17/2026 | 308.83 K | $14.30 M | -31.39% | 0.58% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 300.00 K | $13.89 M | 100.00% | 0.56% |
| MORGAN STANLEY | 02/13/2026 | 287.64 K | $13.32 M | 73.44% | 0.54% |
| ABRDN PLC | 01/16/2026 | 287.46 K | $13.31 M | 100.00% | 0.54% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 287.29 K | $13.30 M | 336.80% | 0.54% |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 02/09/2026 | 275.78 K | $12.80 M | 100.00% | 0.52% |
| CITIGROUP INC | 02/13/2026 | 255.40 K | $11.83 M | 710.79% | 0.48% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 254.90 K | $11.80 M | -36.54% | 0.48% |
| PFM HEALTH SCIENCES, LP | 02/17/2026 | 247.89 K | $11.48 M | 1.85% | 0.46% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 247.05 K | $11.44 M | 59.88% | 0.46% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 244.36 K | $11.31 M | 1,425.52% | 0.46% |
Soleno Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 312 institutional investors and hedge funds held shares of Soleno Therapeutics Inc. The most heavily invested institutionals were:
Pictet Asset Management Holding SA: 616,217
abrdn plc: 287,456
Candriam S.C.A.: 281,620
Bank of New York Mellon Corp: 277,851
EMERALD ADVISERS, LLC: 274,138
UBS Group AG: 225,147
121.60% of Soleno Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 68.81 M shares in the last 24 months. This purchase volume represents approximately $2.74 B in transactions.